TABLE 2.

Characteristics of patients divided into dichotomous SFR categorical variables before matching.

Characteristic	Mean (SD) or median (Q1–Q3)/N (%)		p-Value
	SFR ≤ 0.05 (n = 71)	SFR > 0.05 (n = 132)
Age	80.75 ± 4.28	83.04 ± 5.06	0.001
MoCA	22.00 ± 5.43	18.49 ± 6.42	<0.001
SFR	0.03 ± 0.01	0.10 ± 0.05	<0.001
Creatinine	88.42 ± 36.93	84.65 ± 34.95	0.473
Uric acid	347.27 ± 94.33	350.52 ± 116.81	0.841
α-HBDH	151.09 ± 38.55	149.61 ± 33.70	0.778
HSCRP	3.43 ± 4.17	4.39 ± 11.95	0.514
TC	4.25 ± 0.80	4.16 ± 0.89	0.471
TG	1.25 ± 0.61	1.44 ± 0.83	0.094
HDLC	1.24 ± 0.32	1.17 ± 0.32	0.137
LDLC	2.50 ± 0.64	2.44 ± 0.74	0.563
APOA	1.39 (1.21–1.63)	1.29 (1.12–1.49)	0.005
APOB	0.90 ± 0.22	0.89 ± 0.24	0.688
Fazekas scale, No. (%)			0.002
0	29 (40.8)	26 (19.7)
1	22 (31)	36 (27.3)
2	15 (21.1)	45 (34.1)
3	5 (7)	25 (18.9)
Sex-No. (%)			0.300
Male	49 (69)	100 (75.8)
Female	22 (31)	32 (24.2)
Hypertension, No. (%)			0.301
No	8 (11.3)	22 (16.7)
Yes	63 (88.7)	110 (83.3)
Diabetes, No. (%)			0.087
No	47 (66.2)	71 (53.8)
Yes	24 (33.8)	61 (46.2)
Coronary heart disease, No. (%)			0.956
No	53 (74.6)	99 (75)
Yes	18 (25.4)	33 (25)
Stroke, No. (%)			0.269
No	60 (84.5)	103 (78)
Yes	11 (15.5)	29 (22)

MoCA denotes, Montreal Cognitive Assessment; SFR, Sylvian fissure ratio; α-HBDH, α-hydroxybutyrate dehydrogenase; HSCRP, high-sensitivity C-reactive protein; TC, total cholesterol; TG, total triglyceride; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; APOA, apolipoprotein A; and APOB, apolipoprotein B.